Researchers describe JNK protein's key role in tissue regeneration

July 1, 2014
From left to right, researchers Teresa Adell, María Almuedo-Castillo and Emili Saló at the University of Barcelona.

Researchers from the Department of Genetics of the University of Barcelona (UB) and the Institute of Biomedicine of UB (IBUB) have proved the major role that JNK protein plays in tissue regeneration in adult organisms. The study, published in the journal PLOS Genetics, used planarians —a type of worm able to regenerate any part of its body— to address the question. The study was coordinated by Emili Saló and Teresa Adell, professors from the Department of Genetics of UB. Besides, it is part of the PhD thesis developed by Maria Almuedo Castillo, researcher at UB. Experts from the Max Planck Institute for Molecular Biomedicine (Münster) and the University of Münster (Germany) also participated in the study.

Freshwater planarian flatworm are a popular model system in regeneration and because they are able to regenerate any part of their body, even the head, in two weeks. This amazing plasticity relies on the presence of a population of adult , the neoblasts, which are able to become any type of cell. However, the mechanisms that trigger regeneration remain little known.

JNK: a protein well preserved throughout evolution

UB researchers focused the study on the function of JNK protein, a well-preserved kinase in metazoan evolution. To date, it was known that JNK was involved in the control of cell proliferation and death, but little was known about the role it plays in tissue and organ regeneration.

In the study, JNK functions were blocked through RNA interference in order to observe organism's differences when JNK is activated and deactivated. Teresa Adell, author of the paper, explains that "in any organism, after a wound or an amputation, must be activated in order to generate new cells, as well as , to integrate well new and old tissues". "We —adds the expert— have just discovered that JNK is crucial to control both processes at the same time: the temporal control of the cell cycle progression of and the activation of apoptosis". "We consider that the control that a single protein exerts of both mechanisms at the same time is key to coordinate both responses, so regeneration is developed in a controlled way", concludes Adell.

New factor to create tissues in vitro

JNK is also crucial for planarians' ability to adapt their size in accordance with nutritional supply. Planarians get smaller when there is no food, and they return to their original size when feeding is reinstated. The study proves that JNK acts as a hub in the maintenance of body proportion and the adjustment of the size of organs. "Against tissue loss, JNK modulates gene expression, induces the elimination of unnecessary cells and controls cell division that stem cells need", highlights Maria Almuedo.

This ability to regulate both cell death and stem cell division gives new insights into regenerative medicine, a field in which one of the greatest challenges is to generate and maintain tissues and organs in vitro to transplant them later. These tissues are generated from human pluripotent stem cells and one of the difficulties of the process is to achieve them to be functional and proportioned Planarians' regeneration and remodelling is a model that enables to solve this problem.

"Our study proves that JNK plays a key role in maintaining a balance between cell apoptosis and proliferation in organisms based on pluripotent stem cells like planarians", underlines Emili Saló, professor and head of the Department of Genetics of UB. "Therefore —he concludes—, the regulation of JNK activity will be another factor to bear in mind to optimize stem cell cultures and maintain functional organs in vitro".

JNK deregulation and cancer

JNK loss of function favours the deregulation of cell death and proliferation, a process that has been related to tumour development. The new study points out that the relationship between JNK and cancer is more complex than it was though. "Our results demonstrate that JNK activity inhibition in planarians does not induce tumours. This result points out that JNK's role as carcinogenic agent is not enough to develop a tumour; on the contrary, tumours emerge from an alteration of several signalling pathways that occurs simultaneously", explains Teresa Adell. To study the relationship between JNK and other signalling pathways in tumour process is one of the future research lines of UB research group.

Explore further: Scientists uncover potential drug target to block cell death in Parkinson's disease

More information: "JNK Controls the Onset of Mitosis in Planarian Stem Cells and Triggers Apoptotic Cell Death Required for Regeneration and Remodeling," María Almuedo-Castillo, Xenia Crespo, Florian Seebeck, Kerstin Bartscherer, Emili Salò, Teresa Adell. PLOS GENETICS, Published: June 12, 2014, DOI: 10.1371/journal.pgen.1004400

Related Stories

Scientists uncover potential drug target to block cell death in Parkinson's disease

January 10, 2013
Oxidative stress is a primary villain in a host of diseases that range from cancer and heart failure to Alzheimer's disease, Amyotrophic Lateral Sclerosis and Parkinson's disease. Now, scientists from the Florida campus of ...

Sunday driver gene headed the wrong way in inherited muscle diseases

March 26, 2014
Skeletal muscle cells with unevenly spaced nuclei, or nuclei in the wrong location, are telltale signs of such inherited muscle diseases as Emery-Dreifuss muscular dystrophy, which occurs in one out of every 100,000 births, ...

Signaling to chromatin

January 3, 2012
(Medical Xpress) -- Scientists from the Friedrich Miescher Institute for Biomedical Research (FMI) in collaboration with their colleagues from the Department of Biosystems Science and Engineering of the ETH Zurich, describe ...

Recommended for you

Scientists provide insight into genetic basis of neuropsychiatric disorders

July 21, 2017
A study by scientists at the Children's Medical Center Research Institute at UT Southwestern (CRI) is providing insight into the genetic basis of neuropsychiatric disorders. In this research, the first mouse model of a mutation ...

South Asian genomes could be boon for disease research, scientists say

July 18, 2017
The Indian subcontinent's massive population is nearing 1.5 billion according to recent accounts. But that population is far from monolithic; it's made up of nearly 5,000 well-defined sub-groups, making the region one of ...

Mutant yeast reveals details of the aberrant genomic machinery of children's high-grade gliomas

July 18, 2017
St. Jude Children's Research Hospital biologists have used engineered yeast cells to discover how a mutation that is frequently found in pediatric brain tumor high-grade glioma triggers a cascade of genomic malfunctions.

Late-breaking mutations may play an important role in autism

July 17, 2017
A study of nearly 6,000 families, combining three genetic sequencing technologies, finds that mutations that occur after conception play an important role in autism. A team led by investigators at Boston Children's Hospital ...

Newly identified genetic marker may help detect high-risk flu patients

July 17, 2017
Researchers have discovered an inherited genetic variation that may help identify patients at elevated risk for severe, potentially fatal influenza infections. The scientists have also linked the gene variant to a mechanism ...

Newly discovered gene variants link innate immunity and Alzheimer's disease

July 17, 2017
Three new gene variants, found in a genome wide association study of Alzheimer's disease (AD), point to the brain's immune cells in the onset of the disorder. These genes encode three proteins that are found in microglia, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.